2024
DOI: 10.33590/emj/10307646
|View full text |Cite
|
Sign up to set email alerts
|

Transitioning Patients From Second- to First-Line Prophylaxis in Hereditary Angioedema

Caroline E Cross

Abstract: Modern targeted prophylaxis is recommended for patients with hereditary angioedema (HAE), but many remain on attenuated androgens. EMJ spoke to two HAE experts who explain how they help patients to make the switch.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 20 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?